News
Trend watch: gay Republicans for Congress
Innis seeks N.H. House seat in ‘historic’ year for GOP
Dan Innis is running for Congress in New Hampshire (Washington Blade photo by Michael Key).
The New Hampshire Republican is one of three openly gay Republicans running in the congressional mid-terms along with Richard Tisei in Massachusetts and Carl DeMaio in San Diego.
The significance of the triumvirate of gay GOPers running for Congress at the same time isn’t lost on Innis, who spoke with the Washington Blade during a trip to D.C. last week between meetings on K Street.
“I think it’s an indicator of how far we have moved as a nation because 10 years ago, this wouldn’t be happening,” Innis said. “And we have really come a long way, and I think we will continue to move along this path. To me, it’s a real statement about our continued push for full equality.”
But it’s the Republican aspect of Innis’ candidacy that’s at the forefront of his mind as he seeks to oust incumbent Democrat Rep. Carol Shea-Porter from her seat representing New Hampshire’s 1st congressional district.
During his tenure since 2007 as dean of the College of Business and Economics at the University of New Hampshire, Innis said the young people with whom he works don’t see the world in the same way as he did when he was younger.
“I’ve been working with young people for 23 years in higher education,” Innis said. “I have three kids of my own, 13, 20 and 22. And the way that they see the world today is different from the way that I saw it. They don’t feel the same level of freedom, they don’t feel the same opportunities, they don’t feel that their future is as bright as I felt mine was.”
For Innis, the downward shift has its roots in Washington, and it’s time for New Hampshire to send representatives to Congress “who are not career politicians, who can help to turn things back around, and bring back that sense of optimism about the future.”
Innis earlier this month won an endorsement from the Gay & Lesbian Victory Fund, which has also endorsed Tisei in his bids for Congress. The Victory Fund has yet to endorse DeMaio.
“Dan Innis is a sensible and visionary leader, two qualities New Hampshire constituents deserve in a representative,” said Torey Carter, chief operating officer at the Victory Fund. “His unique combination of corporate and academic backgrounds has allowed him to address issues that affect others with careful consideration.”
Innis said he hasn’t sought an endorsement from the Human Rights Campaign. The Log Cabin Republicans are prohibited from making endorsements in the primary.
Even with the Victory Fund endorsement, the New Hampshire Republican said he doesn’t see LGBT issues as a priority for him if elected as much as the advancement of equality in general.
“I think, for me, it’s about equality for all, and those are the issues that I’ll always champion, so any issue that relates to equality — whether it’s related to gender, race, sexual orientation — those are values that I think all Americans hold, and those are things that I would always fight for,” Innis said. “It’s a broad-based equality mission for me.”
But among the pieces of legislation at the top of his list is the Employment Non-Discrimination Act, a bill that has languished in Congress for years that would prohibit bias against LGBT people in the workforce.
“It’s time that that come up for a vote, and there’s no reason it shouldn’t,” Innis said. “We’ve seen support for that on the Senate side, New Hampshire senators both supported it, Republican and Democrat, and I’m proud of that. And I believe the House will do the right thing.”
The legislation passed in the Senate late last year on a bipartisan vote of 64-32, but House Speaker John Boehner (R-Ohio) has said he opposes it and it hasn’t yet come up for a vote in the Republican-controlled chamber.
Even though his vote first in Congress would be for Republican leadership, Innis said he sees the ability for LGBT legislation to advance under a GOP-controlled House because he’d bring a different voice to the caucus.
“When they’re not there with you, you don’t see it the same way,” Innis said. “The minute I’m sitting down next to John Boehner or somebody else, I’m there, and that bill affects me, and that affects how they perceive that bill, and I think it will really change the way the Republican Party will move forward.”
Innis isn’t alone in his bid for the Republican nomination. Also running is Frank Guinta, a former member of the U.S. House who defeated Shea-Porter in 2010, but lost to her in the 2012 election. The primary is Sept. 9.
A recent WMUR Granite State Poll showed Guinta ahead of Shea-Porter, but Innis behind her. He attributed that discrepancy to name recognition, saying that would change as the campaign gets underway and Super PACs come to his aid.
Although significant gains for LGBT equality have been made under the Obama administration, Innis insisted credit for progress should be given to all who contributed.
“You know, we’ve seen previous presidents, the one before Obama, put an awful lot of money into AIDS research,” Innis said, “And I think that deserves credit. George W. Bush was phenomenal on that. He deserves credit. Any leader who’s taken a stand on these issues deserves credit regardless of party. To me, this is not a partisan issue; this is a human issue.”
Despite his support for LGBT rights, Innis stopped short of endorsing the idea of an executive order barring LGBT workplace bias against federal contractors. No Republican lawmaker or candidate has yet to endorse the order.
“I have some issues with executive orders,” Innis said. “I’m not a big fan of executive orders generally speaking, and I will say I haven’t given this one an awful lot of thought, but I think equality is always a good thing.”
Asked whether he was leaning in favor of supporting the executive order, Innis said he’d like to see an end to LGBT discrimination “done in a more open and participative way.”
Coming from a state where same-sex marriage was made legal in 2009 through the legislative process, Innis had a role in helping resist an effort from a Republican supermajority in the legislature to repeal the statute.
Innis acknowledged he didn’t have an active role in the legalization of same-sex marriage at that time because he had recently come out as gay and was still in his position at the university, but said he lent his voice as a Republican when the law was under threat.
“I guess I was on a brochure that went to all the legislators with my story,” Innis said. “I gave a couple of talks, some things in newspapers, and really I think represented equality in the state in that battle. It became very visible for me. I was featured in the Portsmith Herald on the front page the day after. It was a little more public than I wanted to be, but so be it.”
Innis said he faced criticism for his role in convincing the Republicans to drop efforts to repeal the law, but wouldn’t identify who was unhappy with him.
“I think it’s important to note that that was a Republican legislature that had a veto-proof majority in both houses. Think about that and equality was supported,” Innis said. “That’s New Hampshire. And we believe in equality and freedom for all.”
Innis said he hasn’t yet spoken to the other two gay Republican candidates running for Congress, but said he expects to talk to them soon. He’s also not a member of the joint fundraising committee formed by Tisei and DeMaio called the Equality Leadership Fund. Innis said he’s aware of the fund but remains focused on his campaign.
It should be noted all three openly gay Republicans seeking seats in the U.S. House are trying to oust incumbent Democrats.
Ray Buckley, who’s gay and chair of the New Hampshire Democratic Party, said Shea-Porter is the best candidate because New Hampshire voters expect elected officials “to stand up against injustice and support families of all varieties.”
“Instead, Dan Innis failed to fight for LGBT rights in New Hampshire as the legislature debated marriage equality,” Buckley said. “He failed them again during the fight for the Employee Non-Discrimination Act, in which strong Republican voices could have helped turn the tide, ending the ability to discriminate against someone in the workplace for simply being who they are. Meanwhile, Congresswoman Shea-Porter has consistently been on the right side of history, defending LGBT families and advancing civil rights. Dan Innis is the wrong candidate for families of all kinds in the state of New Hampshire.”
But Innis insisted that he’s the right candidate for the LGBT community because, unlike Shea-Porter, he’s lived the experience of being openly gay.
“I live it and understand it more thoroughly than she ever will. I’m LGBT; Carol Shea-Porter is not,” Innis said. “And though I appreciate her support of the community, I think the support coming from me is genuine and it’s part of me.”
It’s the new voices the gay Republican candidates are bringing to the fore that Innis said are making the campaigns valuable in and of themselves.
“I think we have three historic races,” Innis said. “Races that wouldn’t have taken place not that many years ago. And I think that in and of itself adds value for our community, and if we’re going to move equality forward, we’ve got to do it in every way possible – Republican, Democrat, Libertarian, independent, doesn’t matter — I think that if one or all of us wins, we’re that much closer to equality.”
CORRECTION: An initial version of this article incorrectly stated the Victory Fund endorsed Carl DeMaio. The Blade regrets the error.
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
Rehoboth Beach
Rehoboth’s Blue Moon is for sale but owners aim to keep it in gay-friendly hands
$4.5 million listing includes real estate; business sold separately
Gay gasps could be heard around the DMV earlier this week when a real estate listing for Rehoboth Beach’s iconic Blue Moon bar and restaurant hit social media.
Take a breath. The Moon is for sale but the longtime owners are not in a hurry and are committed to preserving its legacy as a gay-friendly space.
“We had no idea the interest this would create,” Tim Ragan, one of the owners, told the Blade this week. “I guess I was a little naive about that.”
Ragan explained that he and longtime partner Randy Haney are separating the real estate from the business. The two buildings associated with the sale are listed by Carrie Lingo at 35 Baltimore Ave., and include an apartment, the front restaurant (6,600 square feet with three floors and a basement), and a secondary building (roughly 1,800 square feet on two floors). They are listed for $4.5 million.
The bar and restaurant business is being sold separately; the price has not been publicly disclosed.
But Ragan, who has owned the Moon for 20 years, told the Blade nothing is imminent and that the Moon remains open through the holidays and is scheduled to reopen for the 2026 season on Feb. 10. He has already scheduled some 2026 entertainment.
“It’s time to look for the next people who can continue the history of the Moon and cultivate the next chapter,” Ragan said, noting that he turns 70 next year. “We’re not panicked; we separated the building from the business. Some buyers can’t afford both.”
He said there have been many inquiries and they’ve considered some offers but nothing is firm yet.
Given the Moon’s pioneering role in queering Rehoboth Beach since its debut 44 years ago in 1981, many LGBTQ visitors and residents are concerned about losing such an iconic queer space to redevelopment or chain ownership.
“That’s the No. 1 consideration,” Ragan said, “preserving a commitment to the gay community and honoring its history. The legacy needs to continue.” He added that they are not inclined to sell to one of the local restaurant chains.
You can view the real estate listing here.
Child- and pet-proofing your home for the holidays
‘Dogs of Venice’ looks at love lost and rediscovered
A Wider Bridge to close
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
Rehoboth’s Blue Moon is for sale but owners aim to keep it in gay-friendly hands
LGBTQ Democrats say they’re ready to fight to win in 2026
Brian Footer suspends campaign for Ward 1 D.C. Council seat
Lighting candles in a time of exhaustion
2026 elections will bring major changes to D.C. government
Kazakh Senate approves anti-LGBTQ propaganda bill
-
Politics4 days agoLGBTQ Democrats say they’re ready to fight to win in 2026
-
District of Columbia4 days ago
Brian Footer suspends campaign for Ward 1 D.C. Council seat
-
Opinions4 days ago
Lighting candles in a time of exhaustion
-
Opinions3 days ago
2026 elections will bring major changes to D.C. government
